A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
Title: | A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? |
---|---|
Authors: | Araújo, Fernando Antônio Glasner da Rocha, Sumita, Nairo Massakazu, Barroso Jr., Ubirajara de Oliveira |
Source: | International braz j urol. June 2019 45(3) |
Publisher Information: | Sociedade Brasileira de Urologia, 2019. |
Publication Year: | 2019 |
Subject Terms: | Prostatic Neoplasms, Prostate-Specific Antigen, Mass Screening |
More Details: | Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data obtained from a large database between 1997 and 2016. The general PSA screening trend during this period, adjusted for the total number of exams performed in men, was analyzed. Time-series analysis was performed through observation of the general regression curve using the generalized least squares method, and the impact of the recommendations was assessed with autoregressive integrated moving average (ARIMA) models. Results: During the period studied 2,521,383 PSA determinations were done. The age of the participants ranged from 21 to 111 years, with an average of 56.7 ± 22.7 years. The relative number of PSA tests/100.000 exams in males showed a constant reduction since 2001, and this trend was more evident in the group aged 55-69 years. Although statistically significant, the impact of reduced PSA screening after the 2012 USPSTF publication was clinically irrelevant. Conclusions: Our results indicated a continuous reduction in the use of PSA screening over time, regardless of the publication of recommendations or clinical guidelines. The fact that this trend was more pronounced among those with a greater benefit potential (55-69 years), relative to groups with a greater damage potential due to overdiagnosis and overtreatment (aged >74 years and <40 years), is a matter of concern. Follow-up studies of these trends are advisable. |
Document Type: | article |
File Description: | text/html |
Language: | English |
ISSN: | 1677-5538 |
DOI: | 10.1590/s1677-5538.ibju.2018.0179 |
Access URL: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478 |
Rights: | info:eu-repo/semantics/openAccess |
Accession Number: | edssci.S1677.55382019000300478 |
Database: | SciELO |
FullText | Text: Availability: 0 CustomLinks: – Url: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478# Name: EDS - SciELO Category: fullText Text: Full Text from SciELO MouseOverText: Full Text from SciELO – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edssci&genre=article&issn=16775538&ISBN=&volume=45&issue=3&date=20190601&spage=&pages=&title=International braz j urol&atitle=A%20continuous%20fall%20of%20PSA%20use%20for%20prostate%20cancer%20screening%20among%20Brazilian%20doctors%20since%202001.%20Good%20or%20bad%20notice%3F&aulast=Ara%C3%BAjo%2C%20Fernando%20Ant%C3%B4nio%20Glasner%20da%20Rocha&id=DOI:10.1590/s1677-5538.ibju.2018.0179 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edssci DbLabel: SciELO An: edssci.S1677.55382019000300478 RelevancyScore: 934 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 933.754455566406 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Araújo%2C+Fernando+Antônio+Glasner+da+Rocha%22">Araújo, Fernando Antônio Glasner da Rocha</searchLink><br /><searchLink fieldCode="AR" term="%22Sumita%2C+Nairo+Massakazu%22">Sumita, Nairo Massakazu</searchLink><br /><searchLink fieldCode="AR" term="%22Barroso+Jr%2E%2C+Ubirajara+de+Oliveira%22">Barroso Jr., Ubirajara de Oliveira</searchLink> – Name: TitleSource Label: Source Group: Src Data: <i>International braz j urol</i>. June 2019 45(3) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Sociedade Brasileira de Urologia, 2019. – Name: DatePubCY Label: Publication Year Group: Date Data: 2019 – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Prostatic+Neoplasms%22">Prostatic Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Prostate-Specific+Antigen%22">Prostate-Specific Antigen</searchLink><br /><searchLink fieldCode="DE" term="%22Mass+Screening%22">Mass Screening</searchLink> – Name: Abstract Label: Description Group: Ab Data: Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data obtained from a large database between 1997 and 2016. The general PSA screening trend during this period, adjusted for the total number of exams performed in men, was analyzed. Time-series analysis was performed through observation of the general regression curve using the generalized least squares method, and the impact of the recommendations was assessed with autoregressive integrated moving average (ARIMA) models. Results: During the period studied 2,521,383 PSA determinations were done. The age of the participants ranged from 21 to 111 years, with an average of 56.7 ± 22.7 years. The relative number of PSA tests/100.000 exams in males showed a constant reduction since 2001, and this trend was more evident in the group aged 55-69 years. Although statistically significant, the impact of reduced PSA screening after the 2012 USPSTF publication was clinically irrelevant. Conclusions: Our results indicated a continuous reduction in the use of PSA screening over time, regardless of the publication of recommendations or clinical guidelines. The fact that this trend was more pronounced among those with a greater benefit potential (55-69 years), relative to groups with a greater damage potential due to overdiagnosis and overtreatment (aged >74 years and <40 years), is a matter of concern. Follow-up studies of these trends are advisable. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: text/html – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 1677-5538 – Name: DOI Label: DOI Group: ID Data: 10.1590/s1677-5538.ibju.2018.0179 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478" linkWindow="_blank">http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478</link> – Name: Copyright Label: Rights Group: Cpyrght Data: info:eu-repo/semantics/openAccess – Name: AN Label: Accession Number Group: ID Data: edssci.S1677.55382019000300478 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edssci&AN=edssci.S1677.55382019000300478 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1590/s1677-5538.ibju.2018.0179 Languages: – Text: English Subjects: – SubjectFull: Prostatic Neoplasms Type: general – SubjectFull: Prostate-Specific Antigen Type: general – SubjectFull: Mass Screening Type: general Titles: – TitleFull: A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Araújo, Fernando Antônio Glasner da Rocha – PersonEntity: Name: NameFull: Sumita, Nairo Massakazu – PersonEntity: Name: NameFull: Barroso Jr., Ubirajara de Oliveira IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 16775538 Numbering: – Type: volume Value: 45 – Type: issue Value: 3 Titles: – TitleFull: International braz j urol Type: main |
ResultId | 1 |